跳至主要内容
临床试验/NL-OMON54292
NL-OMON54292招募中不适用

A randomized controlled trial to evaluate the safety and efficacy of an 8-week home-based standardized exercise training program for preventing post-pulmonary embolism syndrome: the PE@HOME study - PE@HOME

eids Universitair Medisch Centrum0 个研究点目标入组 156 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
156

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Provision of informed consent prior to any study specific procedures.
  • -Be diagnosed with a confirmed symptomatic acute PE <4 weeks before
  • randomization
  • -Be aged 18 years or older
  • -Report dyspnoea (MRC 2 points or more) and functional limitations (PVFS scale
  • 2 or higher)

排除标准

  • -Incapability to follow study procedures (including but not limited to
  • participate in the exercise training program, have WiFi at the patients house
  • to connect the cycle ergometer to the platform, or follow instructions of the
  • research team and complete the web-based PROMS).
  • -Life expectancy shorter than 6 months
  • -Presence of settings (e.g. pregnancy) or comorbidities (e.g. planned surgery
  • or cancer with systemic anticancer therapy) requiring intensive treatment that
  • would interfere with the exercise program
  • - Chronic dyspnoea in the setting of known or suspected serious cardiopulmonary
  • comorbidities: CTEPH, COPD >GOLD II, heart failure > New York Heart Association
  • Classification (NYHA) 2 or interstitial lung diseases.
  • - Previous inclusion in the study
  • - COVID associated pulmonary embolism
  • - CWRT >15 minutes at baseline
  • - Contra-indication for Cardiopulmonary Exercise Testing (CPET) conform
  • ATS-guideline (e.g. severe right ventricular strain with massive PE)

研究者

相似试验

招募中
3 期
A random allocation study to receive one of the trial intervention, to evaluate the safety of breast conserving surgery (surgery to remove cancer while leaving as much normal breast as possible) after giving neo adjuvant therapy in patients with locally advanced breast cancer (large tumors).
CTRI/2018/07/014767Tata Memorial Centre
招募中
不适用
Point of CARE testing in a general practice setting trialHyperlipidaemia and anticoagulantm therapyMetabolic and Endocrine - DiabetesDiet and Nutrition - Other diet and nutrition disordersDiabetes
ACTRN12605000272695Department of General Practice, The University of Adelaide6,836
招募中
不适用
A randomized controlled trial evaluating the safety and efficacy of the endovascular treatment of subjects with stenotic or restenotic lesions of the common femoral artery with the Supera Vascular Mimetic Implant compared to surgical Common Femoral Artery Endarterectomyperipheral arterial disease
NL-OMON55275ID3 Medical40
已完成
不适用
Topical cyclosporine 2% for herpetic interstitial keratitis
IRCT2015052112724N2Vice chancellor for research, Isfahan University of Medical Sciences48
招募中
2 期
An Open-Label, Multi-Center, Randomized Study Evaluating the Safety and Efficacy of Flutcasone Propionate Nasal Drops, Nasal Spray and Suspension for Nebulization via Nasal Inhalation in Post-Surgical Subjects with Chronic SinusitisChronic SinusitisInflammatory and Immune System - Other inflammatory or immune system disorders
ACTRN12608000140358aryx Pharma, Inc.30